Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Local Coverage With Evidence Development Is Legit, CMS Says; But It May Be Rare

This article was originally published in The Gray Sheet

Executive Summary

CMS issued its final guidance on the coverage-with-evidence-development program, two years following a draft. It is explicit that local Medicare contractors can employ CED in setting coverage policies in their jurisdictions, but it is not clear that the language will encourage significant use at the local level. The guidance also revises its approach on ending CED policies compared to what was stated in the 2012 draft guidance.


Related Content

Medicare 'Coverage With Evidence' May Rise With FDA Postmarket Emphasis
Paying For Placebo Is ‘Biggest Change’ In Medicare CED Policy, Official Says
Louis Jacques On Coverage, Evidence And IDEs
Device Makers Seek Clarity On CMS' Plans For Coverage With Evidence Development
CMS Ambiguous On Role Of Local Contractors In Coverage With Evidence Development
CMS Coverage-With-Evidence-Development Policy Could Face Revamp
CMS Offers Two Paths To “Coverage With Evidence” In Revised Guidance





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts